Nordea Investment Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.66M Buy
17,055
+469
+3% +$89.7K ﹤0.01% 672
2026
Q1
$2.96M Buy
16,586
+2,564
+18% +$472K ﹤0.01% 689
2025
Q4
$2.46M Sell
14,022
-118,561
-89% -$19.4M ﹤0.01% 720
2025
Q3
$18.2M Buy
132,583
+6,648
+5% +$899K 0.02% 348
2025
Q2
$15.8M Buy
125,935
+6,811
+6% +$849K 0.01% 353
2025
Q1
$16.3M Buy
119,124
+1,161
+1% +$166K 0.02% 340
2024
Q4
$17.9M Buy
117,963
+38,283
+48% +$6.46M 0.02% 335
2024
Q3
$15.4M Sell
79,680
-29,794
-27% -$6.23M 0.02% 351
2024
Q2
$25.7M Buy
109,474
+4,098
+4% +$891K 0.03% 305
2024
Q1
$22.7M Sell
105,376
-31,354
-23% -$7.34M 0.03% 327
2023
Q4
$35.4M Sell
136,730
-81,258
-37% -$20M 0.04% 278
2023
Q3
$56.4M Buy
217,988
+78,335
+56% +$21M 0.08% 223
2023
Q2
$39.7M Sell
139,653
-290,317
-68% -$86.4M 0.05% 260
2023
Q1
$119M Buy
429,970
+6,005
+1% +$1.66M 0.17% 147
2022
Q4
$116M Buy
423,965
+8,925
+2% +$2.52M 0.18% 146
2022
Q3
$107M Sell
415,040
-6,408
-2% -$1.36M 0.17% 146
2022
Q2
$85M Sell
421,448
-26,497
-6% -$5.42M 0.13% 176
2022
Q1
$94.8M Sell
447,945
-3,166
-0.7% -$688K 0.12% 181
2021
Q4
$109M Sell
451,111
-5,875
-1% -$1.51M 0.13% 172
2021
Q3
$131M Buy
456,986
+11,987
+3% +$3.93M 0.17% 151
2021
Q2
$154M Sell
444,999
-68,522
-13% -$20.8M 0.21% 134
2021
Q1
$142M Sell
513,521
-3,741
-0.7% -$1.01M 0.21% 129
2020
Q4
$127M Sell
517,262
-3,108
-0.6% -$802K 0.2% 131
2020
Q3
$147M Sell
520,370
-566,816
-52% -$158M 0.28% 84
2020
Q2
$284M Buy
1,087,186
+566,347
+109% +$170M 0.29% 75
2020
Q1
$162M Sell
520,839
-1,202
-0.2% -$365K 0.39% 66
2019
Q4
$155M Buy
522,041
+8,660
+2% +$2.4M 0.31% 79
2019
Q3
$119M Buy
513,381
+9,080
+2% +$2.11M 0.26% 87
2019
Q2
$118M Sell
504,301
-18,935
-4% -$4.37M 0.26% 87
2019
Q1
$124M Buy
523,236
+97,622
+23% +$30.7M 0.26% 87
2018
Q4
$128M Buy
425,614
+2,576
+0.6% +$822K 0.3% 74
2018
Q3
$149M Sell
423,038
-2,510
-0.6% -$864K 0.31% 75
2018
Q2
$124M Sell
425,548
-525
-0.1% -$148K 0.3% 77
2018
Q1
$117M Buy
426,073
+66,647
+19% +$20.7M 0.28% 78
2017
Q4
$115M Buy
359,426
+5,710
+2% +$1.83M 0.27% 78
2017
Q3
$111M Buy
353,716
+11,933
+3% +$3.53M 0.27% 84
2017
Q2
$92.7M Buy
341,783
+3,525
+1% +$932K 0.23% 99
2017
Q1
$92.5M Sell
338,258
-74,597
-18% -$21.1M 0.24% 98
2016
Q4
$117M Buy
412,855
+2,641
+0.6% +$783K 0.31% 74
2016
Q3
$128M Buy
410,214
+17,156
+4% +$5.08M 0.33% 73
2016
Q2
$95M Sell
393,058
-34,569
-8% -$9.11M 0.27% 85
2016
Q1
$111M Buy
427,627
+267,607
+167% +$70.7M 0.34% 81
2015
Q4
$49M Buy
160,020
+133,149
+496% +$38.3M 0.17% 131
2015
Q3
$7.84M Buy
26,871
+338
+1% +$112K 0.03% 228
2015
Q2
$10.7M Buy
26,533
+18,097
+215% +$7.26M 0.04% 214
2015
Q1
$3.56M Sell
8,436
-10,332
-55% -$4.07M 0.01% 273
2014
Q4
$6.37M Sell
18,768
-905
-5% -$293K 0.02% 243
2014
Q3
$6.51M Sell
19,673
-4,112
-17% -$1.36M 0.03% 241
2014
Q2
$7.5M Buy
23,785
+894
+4% +$269K 0.03% 252
2014
Q1
$7M Buy
22,891
+2,806
+14% +$891K 0.03% 253
2013
Q4
$5.62M Buy
20,085
+2,143
+12% +$554K 0.03% 270
2013
Q3
$4.32M Hold
17,942
0.02% 304
2013
Q2
$3.86M Buy
+17,942
New +$3.83M 0.02% 309

Other funds holding BIIB

Nordea Investment Management's BIIB Position: Q2 2026 in Review

Nordea Investment Management increased its Biogen (BIIB) stake by 2.8% in Q2 2026, buying an estimated $89.7K and bringing the position to 17,055 shares worth $3.66M. The position accounts for ﹤0.01% of the portfolio, ranked #672.

Nordea Investment Management first reported a position in BIIB in Q2 2013 and has held it in 53 quarters since. The position peaked at $284M in Q2 2020. 525 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Nordea Investment Management held 17,055 shares of Biogen worth $3.66M as of Q2 2026.
  • Nordea Investment Management bought 469 Biogen shares in Q2 2026, an estimated $89.7K.
  • Biogen made up ﹤0.01% of Nordea Investment Management's portfolio in Q2 2026, its #672 holding.
  • Nordea Investment Management first reported a position in Biogen in Q2 2013 and has held it in 53 quarters since.
  • Nordea Investment Management's Biogen position peaked at $284M in Q2 2020.
  • 525 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Nordea Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.